Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice

Chronobiology International

Volumn 27, Issue 9-10, 2010, Pages 1735-1753

  Hayashida, Satoru ^a   Kuramoto, Yukako ^a   Koyanagi, Satoru ^b   Oishi, Katsutaka ^c   Fujiki, Junya ^a   Matsunaga, Naoya ^b   Ikeda, Eriko ^b   Ohdo, Shigehiro ^b   Shimeno, Hiroshi ^a   Soeda, Shinji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Circadian; Clock genes; Fibrinolytic system; Hyperlipidemia; PAI 1; PPAR ; Retinoid X receptor ; Thrombosis

Indexed keywords

MUS;

EID: 78049290951     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2010.515324     Document Type: Article

References (36)

1. Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart AC, Aber VR, Maseri A, Kluft C. (1988). Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am. J. Cardiol. 62:635-637.
2. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. (1998). Altered constitutive expression of fatty acid metabolizing enzymes in mice lacking the peroxisome proliferator- activated receptor-alpha (PPAR-alpha). J. Biol. Chem. 273:5678-5684.
3. Bergheanu SC, Pons D, Jukema JW, van der Hoeven BL, Liem S-S, Vandenbroucke JP, Rosendaal FR, le Cessie S, Schalij MJ, van der Bom JG. (2009). Myocardial infarction occurs with a similar pattern in the 4G/5G versions of plasminogen activator inhibitor-1. Chronobiol. Int. 26:637-652.
4. Braissant O, Foufellie F, Scotto C, Dauca M, Wahli W. (1996). Differential expression of Peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -ß and -γ in the adult rat. Endocrinology 137:354-366.
5. Braunwald E. (1995). Morning resistance to thrombolytic therapy. Circulation 91:1604-1606.
6. Chen JG, Li X, Huang HY, Liu HL, Liu DG, Song TJ, Ma CG, Ma D, Song HY, Tang QQ. (2006). Identification of a peroxisome proliferator responsive element (PPRE)-like cis-element in mouse plasminogen activator inhibitor-1 gene promoter. Biochem. Biophys. Res. Commun. 347:821-826.
7. Dart AM, Chin-Dusting JP. (1999). Lipids and the endothelium. Cardiovasc. Res. 43:308-322.
8. Desvergne B, Wahli W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649-688.
9. Fujita M, Franklin D. (1987). Diurnal changes in coronary blood flow in conscious dogs. Circulation 76:488-491.
10. Geppert A, Graf S, Beckmann R, Hornykewycz S, Schuster E, Binder BR, Huber K. (1998). Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler. Thromb. Vasc. Biol. 18:1634-1642.
11. Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR. (1988). Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb. Haemost. 60:72-376.
12. Kim J, Matsunaga N, Koyanagi S, Ohdo S. (2009). Clock gene mutation modulates the cellular sensitivity to genotoxic stress through altering the expression of N-methylpurine DNA glycosylase gene. Biochem. Pharmacol. 78:1075-1082.
13. Kudo T, Nakayama E, Suzuki S, Akiyama M, Shibata S. (2004). Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver. Am. J. Physiol. Endocrinol. Metab. 287:E644-E651.
14. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. (2001). Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107:855-867. (Pubitemid 34084977)
15. Lindeman JH, Pijl H, Toet K, Eilers PH, van Ramshorst B, Buijs MM, van Bockel JH, Kooistra T. (2007). Human visceral adipos e tissue and the plasminogen activator inhibitor type 1. Int. J. Obes. 31:1671-1679.
16. Lundesen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M. (2007). PPARα is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360:437-440.
17. Maemura K, de la Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. (2000). CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J. Biol. Chem. 275:36847-36851.
18. Mavri A, Bastelica D, Staels B, El Ayachi S, Juhan-Vague I, Alessi MC. (2004). PPARα deficiency does not modify age dependency but prevents HFD increase in plasma plasminogen activator inhibitor (PAI)-1 as well as insulin resistance. Thromb. Haemost. 91:1051-1052.
19. McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA. (2001). Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105:877-889.
20. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR. (2000). Upregulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021-4031.
21. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. (1987). Circadian variation in the frequency of sudden cardiac death. Circulation 75:131-138.
22. Mussoni L, Mannucci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E. (1992). Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler. Thromb. 12:19-27.
23. Nakamura K, Inoue I, Takahashi S, Komoda T, Katayama S. (2008). Cryptochrome and period proteins are regulated by the CLOCK/BMAL1 gene: crosstalk between the PPARs/RXRalpha-regulated and CLOCK/BMAL1-regulated systems. PPAR Res. www.hindawi.com/journals/ppar/2008/348610.html ).
24. Oishi K, Ohkura N, Wakabayashi M, Shirai H, Sato K, Matsuda J, Atsumi G, Ishida N. (2006). CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J. Thromb. Haemost. 4:1774-1780.
25. Oishi K, Shirai H, Ishida N. (2007). Identification of the circadian clock-regulated E-box element in the mouse plasminogen activator inhibitor-1 gene. J. Thromb. Haemost. 5:428-431.
26. Oishi K, Uchida D, Ishida N. (2008). Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett. 582:3639-3642.
27. Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S. (2010). Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner. Mol. Pharmacol. 78:135-141.
28. Oubina MP, de Las Heras N, Vazquez-Perez S, Cediel E, Sanz-Rosa D, Ruilope LM, Cachofeiro V, Lahera V. (2002). Valsartan improves fibrinolytic balance in atherosclerotic rabbits. J. Hypertens. 20:303-310.
29. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx, J. (1997). Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor-deficient mice. J. Biol. Chem. 272:27307-27312.
30. Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999-1016.
31. Schoonjans K, Staels B, Auwerx J. (1996). The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302:93-109.
32. Singletary JH, Chan D, Samani NJ, Chong NW. (2008). The canonical E-box motif: a target for glucocorticoid action that drives rhythmic mouse Pai-1 transcription in vitro. Gene 420:42-47.
33. Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. (2003). A new euglobulin clot lysis assay for global fibrinolysis. Thromb. Res. 112:329-337.
34. Strandberg L, Lawrence D, Ny T. (1988). The organization of the human plasminogen activator inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family. Eur. J. Biochem. 176:609-616.
35. Tremoli E, Camera M, Maderna P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. (1993). Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscler. Thromb. 13:338-346.
36. Zeiher AM, Drexler H, Wollschlager H, Just H. (1991). Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401.